AstraZeneca (LSE:AZN) Puts AI Into Biologics Labs With New Discovery Tie Up

AstraZeneca (LSE:AZN) has launched a new AI-driven biologics discovery collaboration with Carterra, announced ahead of ...
Hoodline

AstraZeneca Pours $1 Billion Into Cambridge Lab, Vows 50% Staff Surge

AstraZeneca just opened an 18-story Cambridge research tower — and it's only the start of a $1 billion bet on Massachusetts.
MarketScreener

Carterra, Inc. Announces Research Collaboration With AstraZeneca To Advance Lab-In-The-Loop Drug Discovery

Carterra, Inc. announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery. The effort brings together scientific and ...

What to know about AstraZeneca’s tremendous new R&D center in Kendall Square

The biopharmaceutical company plans to expand its Massachusetts workforce by over 50% as the industry faces broader headwinds. The post What to know about AstraZeneca’s tremendous new R&D center in ...
AZOM

5 Lessons from AstraZeneca, Labman, and Alexion Pharmaceuticals on Building Successful Automation Partnerships

This SLAS US 2026 tutorial brings together automation executives from Labman, AstraZeneca, and Alexion to discuss how strategic alliances can speed up the adoption of advanced chemical automation.
BioSpace

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

Together with its site for genomic medicine at 100 Binney Street, The AstraZeneca R&D Center Kendall Square will be home to nearly 2,000 world-class researchers and scientists who will accelerate the ...